Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT01134692
Eligibility Criteria:
Inclusion Criteria:
Consecutive patients of cirrhosis with portal hypertension who fulfill the following criteria:
1. Diagnosed cases of cirrhosis (by clinical, biochemical and radiological criteria with or without liver biopsy)
2. No history of upper GI bleeding in the past
3. Endoscopically documented large esophageal varices
Exclusion Criteria:
1. history of gastrointestinal bleeding
2. patients who have received beta blockers for portal hypertension in the past 6 weeks.
3. hepatic encephalopathy
4. ongoing bacterial infection,
5. Spontaneous bacterial peritonitis
6. active alcoholism or illicit drug abuse
7. alcoholic hepatitis
8. Treatment with antibiotics in the preceding 2 weeks.
9. presence of hepatocellular carcinoma,
10. portal vein thrombosis
11. serum creatinine\>1.5 mg/dL,
12. treatment with vasoactive drugs in the past 6 weeks,
13. history of arterial hypertension, congestive heart failure or arterial occlusive disease, and
14. Refusal to participate.
15. Active smokers.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
75 Years
Study:
NCT01134692
Study Brief:
Protocol Section:
NCT01134692